Drug Development

Rui Sousa, Ph.D., UT Health San Antonio
September 5, 2017
 

UT Health San Antonio researchers and co-authors in New York state on Monday (Sept. 4) reported an innovative approach that will enable scientists to study the most common regulator of our bodies’ cells, a molecule called guanosine-5′-triphosphate (GTP). Nature Methods, the world’s most prestigious journal for reporting novel biomedical technologies, published the team’s findings. The […]

Read More